Luo Hai
Luo Hai has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Kemin Wang
Hunan University
10 shared publications Dinggeng He
9 shared publicationsXiaoxiao He
9 shared publications- Dinggeng He
Hunan Normal University
7 shared publications Tianzheng Wang
5 shared publicationsAnman Zhang
4 shared publications
Latest Publications
- 25 September 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (20) , 9958-9971
Biomimetic Coacervate Microdroplets Capable of Generating Nitric Oxide and Photonic Hyperpyrexia for Bacterial Killing and Wound Disinfection
Wound bacterial infections pose a serious threat to human health. Nitric oxide (NO) is a broad-spectrum antimicrobial agent and widely participates in immune response, tissue repair, and inflammation regulation. The in situ controllable generation of NO is of crucial importance for the development of NO-based antibacterial agents. Herein, we have constructed a biomimetic, primitive cell-inspired antibacterial coacervate microdroplet for multimode synergistic antibacterial therapy and accelerating wound healing. In this system, the dual-functional photosensitizer indocyanine green (ICG) and the NO prodrug l-arginine (l-Arg) were co-encapsulated into a phospholipid-coated coacervate by liquid–liquid phase separation, yielding a near-infrared (NIR)-activatable NO-releasing platform (IACoac@M). Upon NIR laser irradiation, the loaded ICG not only directly generated the photonic hyperpyrexia for bacterial killing but also performed a photodynamic process for producing singlet oxygen (1O2) that further oxidated l-Arg into NO. The NO production suppresses the expression of the bacterial molecular chaperone DnaK, a heat shock protein, promoting the photothermal therapy. By the combination of multiple bactericidal modalities, IACoac@M showed high antibacterial activities against Gram-positive S. aureus and Gram-negative E. coli. Further in vivo animal assays revealed that IACoac@M could effectively eliminate bacteria cells in wound tissue; inhibit inflammatory factors; and promote angiogenesis, collagen deposition, and epidermal regeneration, thereby accelerating the wound healing process. This study provided a rationally designed multifunctional coacervate capable of generating NO and photonic hyperpyrexia for photothermal/photodynamic/gas trimode synergistic antibacterial therapy, offering a potential solution for the treatment of wound bacterial infections.
- 25 September 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (20) , 9958-9971
Biomimetic Coacervate Microdroplets Capable of Generating Nitric Oxide and Photonic Hyperpyrexia for Bacterial Killing and Wound Disinfection
Wound bacterial infections pose a serious threat to human health. Nitric oxide (NO) is a broad-spectrum antimicrobial agent and widely participates in immune response, tissue repair, and inflammation regulation. The in situ controllable generation of NO is of crucial importance for the development of NO-based antibacterial agents. Herein, we have constructed a biomimetic, primitive cell-inspired antibacterial coacervate microdroplet for multimode synergistic antibacterial therapy and accelerating wound healing. In this system, the dual-functional photosensitizer indocyanine green (ICG) and the NO prodrug l-arginine (l-Arg) were co-encapsulated into a phospholipid-coated coacervate by liquid–liquid phase separation, yielding a near-infrared (NIR)-activatable NO-releasing platform (IACoac@M). Upon NIR laser irradiation, the loaded ICG not only directly generated the photonic hyperpyrexia for bacterial killing but also performed a photodynamic process for producing singlet oxygen (1O2) that further oxidated l-Arg into NO. The NO production suppresses the expression of the bacterial molecular chaperone DnaK, a heat shock protein, promoting the photothermal therapy. By the combination of multiple bactericidal modalities, IACoac@M showed high antibacterial activities against Gram-positive S. aureus and Gram-negative E. coli. Further in vivo animal assays revealed that IACoac@M could effectively eliminate bacteria cells in wound tissue; inhibit inflammatory factors; and promote angiogenesis, collagen deposition, and epidermal regeneration, thereby accelerating the wound healing process. This study provided a rationally designed multifunctional coacervate capable of generating NO and photonic hyperpyrexia for photothermal/photodynamic/gas trimode synergistic antibacterial therapy, offering a potential solution for the treatment of wound bacterial infections.
- 10 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (46) , 63652-63661
Manganese-Doped Hollow Cerium Oxide Nanozyme as a Potent Cigarette Smoke Purifier for Vapor-Phase Reactive Oxygen Species Scavenging
Tobacco smoke-induced lung disease remains a major global health threat. Reactive oxygen species (ROS) present in cigarette smoke including superoxide (•O2-), hydroxyl radicals (•OH), and hydrogen peroxide (H2O2) contribute substantially to oxidative injury, yet conventional acetate filters are ineffective at removing these gaseous free radicals. Here, we report manganese-doped hollow cerium oxide (Mn-CeO2) nanospheres as robust antioxidative nanozymes for scavenging gas-phase ROS. Mn-CeO2 exhibits enhanced superoxide dismutase (SOD)-like, catalase (CAT)-like activities and superior •OH scavenging compared with undoped CeO2. After being filled into a commercial cigarette filter, Mn-CeO2 removed over 56.2% of targeted ROS from smoke under our test conditions. In a mouse passive-smoking model, cigarette filters filled with Mn-CeO2 markedly reduced pulmonary inflammation and histological lung injury relative to the controls. Serum biochemical markers showed no significant systemic toxicity. Our research demonstrates that manganese doping significantly improves the ROS scavenging performance of CeO2 nanozymes and suggests a feasible route to reduce cigarette smoke-derived oxidative damage.
- 10 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (46) , 63652-63661
Manganese-Doped Hollow Cerium Oxide Nanozyme as a Potent Cigarette Smoke Purifier for Vapor-Phase Reactive Oxygen Species Scavenging
Tobacco smoke-induced lung disease remains a major global health threat. Reactive oxygen species (ROS) present in cigarette smoke including superoxide (•O2-), hydroxyl radicals (•OH), and hydrogen peroxide (H2O2) contribute substantially to oxidative injury, yet conventional acetate filters are ineffective at removing these gaseous free radicals. Here, we report manganese-doped hollow cerium oxide (Mn-CeO2) nanospheres as robust antioxidative nanozymes for scavenging gas-phase ROS. Mn-CeO2 exhibits enhanced superoxide dismutase (SOD)-like, catalase (CAT)-like activities and superior •OH scavenging compared with undoped CeO2. After being filled into a commercial cigarette filter, Mn-CeO2 removed over 56.2% of targeted ROS from smoke under our test conditions. In a mouse passive-smoking model, cigarette filters filled with Mn-CeO2 markedly reduced pulmonary inflammation and histological lung injury relative to the controls. Serum biochemical markers showed no significant systemic toxicity. Our research demonstrates that manganese doping significantly improves the ROS scavenging performance of CeO2 nanozymes and suggests a feasible route to reduce cigarette smoke-derived oxidative damage.
- Open Access
- 23 August 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (8) , e1014
Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer
Background: Cancer cell–specific variation and circulating tumour DNA (ctDNA) methylation are promising biomarkers for non‐invasive cancer detection and molecular classification. Nevertheless, the applications of ctDNA to the early detection and screening of cancer remain highly challenging due to the scarcity of cancer cell–specific ctDNA, the low signal‐to‐noise ratio of DNA variation, and the lack of non‐locus‐specific DNA methylation technologies.Methods: We enrolled three cohorts of breast cancer (BC) patients from two hospitals in China (BC: n = 123; healthy controls: n = 40). We developed a ctDNA whole‐genome bisulfite sequencing technology employing robust trace ctDNA capture from up to 200 μL plasma, mini‐input (1 ng) library preparation, unbiased genome‐wide coverage and comprehensive computational methods.Results: A diagnostic signature comprising 15 ctDNA methylation markers exhibited high accuracy in the early (area under the curve [AUC] of 0.967) and advanced (AUC of 0.971) BC stages in multicentre patient cohorts. Furthermore, we revealed a ctDNA methylation signature that discriminates estrogen receptor status (Training set: AUC of 0.984 and Test set: AUC of 0.780). Different cancer types, including hepatocellular carcinoma and lung cancer, could also be well distinguished.Conclusions: Our study provides a toolset to generate unbiased whole‐genome ctDNA methylomes with a minimal amount of plasma to develop highly specific and sensitive biomarkers for the early diagnosis and molecular subtyping of cancer.
- 23 August 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (8) , e1014
Open AccessWhole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer
Background: Cancer cell–specific variation and circulating tumour DNA (ctDNA) methylation are promising biomarkers for non‐invasive cancer detection and molecular classification. Nevertheless, the applications of ctDNA to the early detection and screening of cancer remain highly challenging due to the scarcity of cancer cell–specific ctDNA, the low signal‐to‐noise ratio of DNA variation, and the lack of non‐locus‐specific DNA methylation technologies.Methods: We enrolled three cohorts of breast cancer (BC) patients from two hospitals in China (BC: n = 123; healthy controls: n = 40). We developed a ctDNA whole‐genome bisulfite sequencing technology employing robust trace ctDNA capture from up to 200 μL plasma, mini‐input (1 ng) library preparation, unbiased genome‐wide coverage and comprehensive computational methods.Results: A diagnostic signature comprising 15 ctDNA methylation markers exhibited high accuracy in the early (area under the curve [AUC] of 0.967) and advanced (AUC of 0.971) BC stages in multicentre patient cohorts. Furthermore, we revealed a ctDNA methylation signature that discriminates estrogen receptor status (Training set: AUC of 0.984 and Test set: AUC of 0.780). Different cancer types, including hepatocellular carcinoma and lung cancer, could also be well distinguished.Conclusions: Our study provides a toolset to generate unbiased whole‐genome ctDNA methylomes with a minimal amount of plasma to develop highly specific and sensitive biomarkers for the early diagnosis and molecular subtyping of cancer.
- Open Access
Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
The changes in circulating tumor DNA (ctDNA) methylation are believed to be early events in breast cancer initiation, which makes them suitable as promising biomarkers for early diagnosis. However, applying ctDNA in breast cancer early diagnosis remains highly challenging due to the contamination of background DNA from blood and low DNA methylation signals. Here, we report an improved way to extract ctDNA, reduce background contamination, and build a whole‐genome bisulfite sequencing (WGBS) library from different stages of breast cancer. We first compared the DNA methylation data of 74 breast cancer patients with those of seven normal controls to screen candidate methylation CpG site biomarkers for breast cancer diagnosis. The obtained 26 candidate ctDNA methylation biomarkers produced high accuracy in breast cancer patients (area under the curve [AUC] = 0.889; sensitivity: 100%; specificity: 75%). Furthermore, we revealed potential ctDNA methylated CpG sites for detecting early‐stage breast cancer (AUC = 0.783; sensitivity: 93.44%; specificity: 50%). In addition, different subtypes of breast cancer could be well distinguished by the ctDNA methylome, which was obtained through our improved ctDNA‐WGBS method. Overall, we identified high specificity and sensitivity breast cancer‐specific methylation CpG site biomarkers, and they will be expected to have the potential to be translated to clinical practice.
Open AccessWhole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
The changes in circulating tumor DNA (ctDNA) methylation are believed to be early events in breast cancer initiation, which makes them suitable as promising biomarkers for early diagnosis. However, applying ctDNA in breast cancer early diagnosis remains highly challenging due to the contamination of background DNA from blood and low DNA methylation signals. Here, we report an improved way to extract ctDNA, reduce background contamination, and build a whole‐genome bisulfite sequencing (WGBS) library from different stages of breast cancer. We first compared the DNA methylation data of 74 breast cancer patients with those of seven normal controls to screen candidate methylation CpG site biomarkers for breast cancer diagnosis. The obtained 26 candidate ctDNA methylation biomarkers produced high accuracy in breast cancer patients (area under the curve [AUC] = 0.889; sensitivity: 100%; specificity: 75%). Furthermore, we revealed potential ctDNA methylated CpG sites for detecting early‐stage breast cancer (AUC = 0.783; sensitivity: 93.44%; specificity: 50%). In addition, different subtypes of breast cancer could be well distinguished by the ctDNA methylome, which was obtained through our improved ctDNA‐WGBS method. Overall, we identified high specificity and sensitivity breast cancer‐specific methylation CpG site biomarkers, and they will be expected to have the potential to be translated to clinical practice.
- 1 December 2020
- Published by Elsevier in Chinese Chemical Letters
- Vol. 31 (12) , 3158-3162
NIR-triggered drug delivery system based on phospholipid coated ordered mesoporous carbon for synergistic chemo-photothermal therapy of cancer cells
- 1 December 2020
- Published by Elsevier in Chinese Chemical Letters
- Vol. 31 (12) , 3158-3162
NIR-triggered drug delivery system based on phospholipid coated ordered mesoporous carbon for synergistic chemo-photothermal therapy of cancer cells
- Open Access
- 15 July 2020
- Published by Wiley in Clinical and Translational Medicine
- Vol. 10 (3)
Whole‐genome methylome analysis reveals age‐related diabetes risk factors
This study provides a new perspective on the relationship between age‐related DNA methylation and insulin function. The hexokinase‐1 (HK1 )’s methylation level in the whole blood can be considered as a potential biomarker for the risk of diabetes in healthy individuals.
- 15 July 2020
- Published by Wiley in Clinical and Translational Medicine
- Vol. 10 (3)
Open AccessWhole‐genome methylome analysis reveals age‐related diabetes risk factors
This study provides a new perspective on the relationship between age‐related DNA methylation and insulin function. The hexokinase‐1 (HK1 )’s methylation level in the whole blood can be considered as a potential biomarker for the risk of diabetes in healthy individuals.
- 1 January 2020
- Published by Elsevier in Chinese Chemical Letters
- Vol. 31 (1) , 189-192
A photosensitizer-loaded zinc oxide-polydopamine core-shell nanotherapeutic agent for photodynamic and photothermal synergistic therapy of cancer cells
- 1 January 2020
- Published by Elsevier in Chinese Chemical Letters
- Vol. 31 (1) , 189-192
A photosensitizer-loaded zinc oxide-polydopamine core-shell nanotherapeutic agent for photodynamic and photothermal synergistic therapy of cancer cells